Maternal selective serotonin reuptake inhibitor (SSRI) use is common during pregnancy. However, its effect on the maternal SSRI infant microbiome is still being uncovered. Because the infant gut microbiome is critical for immune training and metabolic programming, understanding these changes is vital. Therefore, a recent pilot study investigated how SSRI exposure shapes early microbial life in 20 maternal-infant dyads.

The Link Between Maternal SSRI and Infant Microbiome Diversity

The pilot study assessed stool samples at two early life stages: 1-2 weeks and 4-6 weeks of life. Researchers found that maternal antidepressant use was not associated with alpha diversity within the samples. Nevertheless, SSRI use may shape beta diversity, which reflects differences between microbial communities. Specifically, this shift was most notable between weeks 4 and 6 of life. Consequently, these findings suggest a modest but significant influence on how microbial communities develop in the neonatal gut.

Specific Taxonomic Shifts in Exposed Infants

Additionally, the investigation revealed significant shifts in specific bacterial genera associated with antidepressant exposure. Infants with maternal SSRI exposure showed increased levels of Gemella, Staphylococcus, and Corynebacterium. Furthermore, the results showed a decrease in Lactobacillus, a genus often associated with beneficial health outcomes. Although these findings are preliminary, they provide a necessary foundation for future functional studies. Ultimately, techniques like metagenomics will be required to assess the clinical relevance of these shifts on systemic health. Moreover, researchers noted that feeding patterns and delivery modes were important covariates to consider in future longitudinal studies.

FAQ: Understanding Maternal SSRI Infant Microbiome Changes

Does maternal SSRI use change infant gut bacteria?

Current research indicates a modest influence on the maternal SSRI infant microbiome. It primarily affects beta diversity, which refers to the differences in microbial composition between different individuals rather than the total species count within one person.

Which bacterial groups are most impacted by antidepressants during pregnancy?

Observations from recent pilot data show increases in Gemella and Staphylococcus. In contrast, beneficial bacteria like Lactobacillus may show a decrease following maternal SSRI exposure, suggesting a shift in the early colonizing microbial community.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Always seek the advice of a qualified physician with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Desorcy-Scherer K et al. Early Insights Into Maternal Antidepressant Use and the Human Infant Gut Microbiome. Biol Res Nurs. 2026 Feb 07. doi: 10.1177/10998004261423546. PMID: 41652998.


2. Desorcy-Scherer K, et al. Selective serotonin reuptake inhibitors during pregnancy and lactation: A scoping review of effects on the maternal and infant gut microbiome. Dev Psychobiol. 2024;66(1):e22441.


3. Margolis KG, et al. Antidepressants in Pregnancy Linked to Children's Gut Issues. NYU Langone Health Physician Focus. 2023.

"